Category Specific RSS

News

Apiam Animal Health acquires leading animal consulting business in Victoria

In an offer too good to refuse, owners of privately-held veterinary company Grampians Animal Health have sold the business to Apiam Animal Health (ASX: AHX) for $4.65m. 

Located in Hamilton, Victoria – the heartland of Victorian sheep farming – the purchase will see Apiam acquire the animal veterinary clinic as well as Livestock Logic, a respected animal production consultancy business which operates throughout Victoria, New South Wales and South Australia. 

Between the two businesses, Grampian Animal Health generated $4.1m revenue in FY19 which would have the acquisition price slightly higher than industry averages, but reflective of the Livestock Logic’s growth opportunity once integrated into the Apiam Group. 

“The acquisition of GAH will significantly enhance Apiam’s operations in the Western District of Victoria and leverage our asset base and infrastructure in this region,” said Apiam Managing Director, Dr Chris Richards. 

“This is a fundamental pillar of our regional expansion strategy, and will take our South West Victorian operating region to 7 clinics.

“GAH also offers Apiam new skills and expertise in sheep consulting services and parasitology diagnostics that can be further expanded through our extensive network of production animal veterinarians in other regions of Australia.” 

Terms of the acquisition will see owners of GAH accept 70% of the purchase price in cash and 30% in AHX shares with half of the shares issued to be held in escrow for 12 months, and the other half, 24 months. There is also a deferred consideration component of $300,000 subject to business performance. 

Since listing on the ASX in 2016, Apiam Animal Health has grown its national footprint to operate in 42 locations around Australia through a mix of its veterinary services, product sales and laboratory services. 

In FY19, Apiam Animal Health reported revenues of $111.7m, a rise of 4.8% from FY18 but of greater note was the increase of 48.4% on gross margins highlighting the actualisation of Group synergy from its acquisitions. 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago